Oncopharmpod
Mosunetuzumab And Same-day Pegfilgrastim w/ ddAC
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:20:35
- More information
Informações:
Synopsis
New Year - New Drug, mosunetuzumab (a CD3-CD20 T-cell engager) is approved for r/r Follicular Lymphoma. And an intriguing retrospective cohort study found a higher rate of neutropenia with same-day pegfilgrastim in patients receiving dose-dense AC. Link: https://doi.org/10.1177/10781552221148116